Skip to main content

C392 (Deferasirox 180 mg)

Pill with imprint C392 is Pink, Capsule-shape and has been identified as Deferasirox 180 mg. It is supplied by Cipla USA, Inc..

Deferasirox is used in the treatment of thalassemia; iron overload; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C392

Deferasirox

Imprint
C392
Strength
180 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Chelating agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
National Drug Code (NDC)
69097-0392

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.